Liquidia (LQDA) Other financing activities (2020)

Liquidia (LQDA) recorded quarterly Other financing activities of $209000.0 in Q3 2020, down 84.59% quarter-over-quarter from $1.4 million in Q2 2020.

Liquidia (LQDA) Other financing activities (2020) Analysis & Trends

Liquidia's Other financing activities history runs 1 years deep, the most recent figure standing at $209000.0 for Q3 2020.

In Q3 2020, Other financing activities changed N/A year-over-year to $209000.0; the TTM figure through Jun 2021 stood at $209000.0 (changed N/A YoY), while the FY2020 annual figure was $1.6 million, changed N/A from the prior year.
Other financing activities was $209000.0 for Q3 2020 at Liquidia, down from $1.4 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $1.4 million in Q2 2020 to a low of $68965.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.77 Bn	35.04 Bn	1.97 Bn
2	Zoetis	34.11 Bn	32.16 Bn	1.62 Bn
3	United Therapeutics	23.68 Bn	21.53 Bn	648.10 Mn
4	Aurora Cannabis	16.48 Bn	16.40 Bn	33.43 Mn
5	Neurocrine Biosciences	16.19 Bn	14.88 Bn	800.70 Mn
6	Elanco Animal Health	11.44 Bn	11.01 Bn	785.00 Mn
7	Alkermes	7.28 Bn	6.77 Bn	-116.06 Mn
8	Lantheus Holdings	6.48 Bn	5.98 Bn	230.92 Mn
9	Hims & Hers Health	6.35 Bn	5.60 Bn	396.79 Mn
10	Liquidia	5.74 Bn	5.52 Bn	121.79 Mn

Download Data